Safety and Immunologic Activity of Multiple Infusions of APN401
Phase of Trial: Phase I
Latest Information Update: 29 Dec 2018
At a glance
- Drugs APN 401 (Primary)
- Indications Colorectal cancer; Pancreatic cancer; Solid tumours
- Focus Adverse reactions
- 28 Sep 2018 Planned End Date changed from 1 Oct 2018 to 1 Mar 2019.
- 28 Sep 2018 Planned primary completion date changed from 1 Oct 2018 to 1 Mar 2019.
- 05 Jun 2018 Results (n=16) presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History